As many as 65 children in Uzbekistan died after being given the Indian cough and cold syrup "Doc-1 Max", a representative of the Uzbek Supreme Court said on August 11. Officials in the country have previously only referred to around 20 victims.
A criminal case centred on the deaths caused by the contaminated medicine began on August 11 in Uzbekistan. The court heard that 21 people, all Uzbek citizens apart from one citizen of India, who is the director of Quramax Medikal, were being held in the case.
Charges pressed include tax evasion, the production, manufacture, acquisition, storage, transportation for sale or sale of substandard or falsified medicines or medical products, abuse of office, negligence, forgery and bribery.
In December 2022, the cough syrup Doc-1 Max, produced by Indian company Marion Biotech, was associated with the deaths of at least 20 children in Uzbekistan.
The Indian regulator later cancelled the manufacturing licence of Marion Biotech, which exported the medicines to Uzbekistan, and arrested some of its employees.
Don’t just follow the news—understand it.
The IntelliNews PRO service includes access to reports, exclusive market data, and more news that decision-makers care about. Stay ahead of the market with IntelliNews PRO.
Sign Up NowRelated Articles
BRICS+ city network voices solidarity with Tehran as tensions with US persist
Senior figures from the BRICS+ Association of Cities and Municipalities expressed “solidarity” with Tehran and voiced concern over developments in the Middle East in a message to the Iranian ... more
Germany’s Uniper signs 10-year LNG supply deal with India
Germany’s state-owned energy firm Uniper has inked a 10-year LNG supply deal with Gujarat State Petroleum Corporation (GSPC), the Dusseldorf-based company announced on February 20. Under the ... more
India expresses interest in US LNG
India would be open to purchasing LNG from the US if the world’s biggest supplier of the super-chilled fuel offered reasonable prices, the CEO of state-owned Petronet said on February 12, Reuters ... more